Proteostasis Therapeutics
Merged with Yumanity Therapeutics in 2020
Developing therapies targeting protein misfolding diseases.
Investment Team
Sector
Life SciencesCategory
TherapeuticsStatus
AcquiredLocation
Cambridge, MAInitial Investment
2008
Developing therapies targeting protein misfolding diseases.
Proteostasis Therapeutics (NASDAQ: PTI) is a drug discovery company developing small molecule therapeutics to treat cystic fibrosis and other diseases caused by dysfunctional protein processing. Proteostasis Therapeutics merged with Yumanity Therapeutics in 2020.